Compugroup Medical (ETR:COP) PT Set at €60.00 by Warburg Research

Compugroup Medical (ETR:COP) received a €60.00 ($69.77) target price from investment analysts at Warburg Research in a research report issued to clients and investors on Thursday, September 19th, Borsen Zeitung reports. The firm presently has a “neutral” rating on the stock. Warburg Research’s price target suggests a potential upside of 11.42% from the stock’s previous close.

Other analysts also recently issued research reports about the company. Berenberg Bank set a €70.00 ($81.40) price target on Compugroup Medical and gave the company a “neutral” rating in a research report on Thursday, August 1st. Deutsche Bank set a €68.00 ($79.07) price target on Compugroup Medical and gave the company a “buy” rating in a research report on Wednesday, August 21st. Kepler Capital Markets set a €60.00 ($69.77) price target on Compugroup Medical and gave the company a “neutral” rating in a research report on Monday, September 16th. Baader Bank set a €52.00 ($60.47) price target on Compugroup Medical and gave the company a “neutral” rating in a research report on Monday, September 16th. Finally, HSBC set a €59.00 ($68.60) price target on Compugroup Medical and gave the company a “buy” rating in a research report on Wednesday, August 21st. One analyst has rated the stock with a sell rating, four have assigned a hold rating and three have assigned a buy rating to the stock. The company presently has a consensus rating of “Hold” and a consensus target price of €57.75 ($67.15).

Shares of COP traded up €1.05 ($1.22) during trading hours on Thursday, reaching €53.85 ($62.62). 62,997 shares of the company’s stock traded hands, compared to its average volume of 68,245. The stock has a market cap of $2.63 billion and a PE ratio of 33.02. The company has a current ratio of 0.90, a quick ratio of 0.70 and a debt-to-equity ratio of 147.29. The firm’s 50 day simple moving average is €52.76 and its 200-day simple moving average is €59.94. Compugroup Medical has a 12 month low of €37.88 ($44.05) and a 12 month high of €74.80 ($86.98).

About Compugroup Medical

CompuGroup Medical Societas Europaea develops and sells software and information technology services for healthcare sector worldwide. The company's Ambulatory Information Systems segment provides practice management software and electronic medical records for office-based physicians, dentists, medical care centers, and physician's networks.

Recommended Story: When is a capital gain realized?

Analyst Recommendations for Compugroup Medical (ETR:COP)

Receive News & Ratings for Compugroup Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Compugroup Medical and related companies with MarketBeat.com's FREE daily email newsletter.